Feature Friday: Dr. Cousin
#FeatureFriday Congratulations to Dr. Cousin, CaRE2 Early Stage Investigator, for being accepted into the EIAP program through the NCI. This program will assist Dr. Cousin to attain an R01 or R-type grant🎉👏 Read more: https://www.cancer.gov/about-nci/organization/crchd/diversity-training/eiap #CaRE2HEC #ESI #R01 #Grant #Funding #NIH #EIAP
Congratulations Dr. Lamba
Congratulations to CaRE2 TMDDC member, Dr. Lamba, for receiving the UFHCC Top Influencer Award of the Year!🎖️🎉 #Award #DrugDevelopment #CancerResearch #CaRE2HEC
CaRE2 Monthly Webinar with Dr. Okunieff
Please join us January 30 for our CaRE2 Monthly Webinar at 11AM PST/2PM EST via Zoom. Our guest speaker will feature Dr. Okunieff, CaRE2 Tissues Modeling and Drug Development Core. Registration link: https://ow.ly/4GiS50Qu6ap
Congratulations Dr. Rogers
Congratulations to CaRE2 Early Stage Investigator, Dr. Rogers, for receiving the UFHCC rising star of the year award🎖️🎉
Congratulations Dr. Cousin
Congratulations to CaRE2 Early Stage Investigator, Dr. Cousin, for receiving the UFHCC rising star of the year award!!🎖️🎉
Join our BSMC Webinar Series on 1/30
Please join us on January 30 for a CaRE2 Bioinformatics Core Webinar Series held from 12-1PM EST/9-10AM PST via Zoom. Register in advance: https://ow.ly/V2L050QsOWb Visit our CaRE2 Bioinformatics website: https://ow.ly/rj2m50QsOW6 #CaRE2HEC #CaRE2 #CancerResearch #Bioinformatics
Training Tuesday!
Join us in celebrating our new CaRE2 Postbac 2023-24, Miles Jordan. 🧪🔬👩🏽🔬 #CancerResearch#CaRE2#CaRE2HEC#TrainingTuesday
Training Tuesday!
Join us in celebrating our new CaRE2 graduate student, Lakasjah Brown. 🧪🔬👩🏽🔬 #CancerResearch #CaRE2 #CaRE2HEC #CaRE2Grad+ #TrainingTuesday
Happy Holidays!
CaRE2 wishes all of You a BEAUTIFUL Holiday Season and a Healthy New Year!!!
5th Annual Cancer in the Community Conference
On Saturday, December 16th, USC hosted their 5th Annual Cancer in the Community Conference. Topics covered included colorectal and prostate cancer, and patient engagement in cancer research. About 90 people joined this hybrid event. 🧬🔬🩺
